Literature DB >> 20433809

Intracellular translocation of calmodulin and Ca2+/calmodulin-dependent protein kinase II during the development of hypertrophy in neonatal cardiomyocytes.

Jaya Pal Gangopadhyay1, Noriaki Ikemoto.   

Abstract

We have recently shown that stimulation of cultured neonatal cardiomyocytes with endothelin-1 (ET-1) first produces conformational disorder within the ryanodine receptor (RyR2) and diastolic Ca(2+) leak from the sarcoplasmic reticulum (SR), then develops hypertrophy (HT) in the cardiomyocytes (Hamada et al., 2009 [3]). The present paper addresses the following question. By what mechanism does crosstalk between defective operation of RyR2 and activation of the HT gene program occur? Here we show that the immuno-stain of calmodulin (CaM) is localized chiefly in the cytoplasmic area in the control cells; whereas, in the ET-1-treated/hypertrophied cells, major immuno-staining is localized in the nuclear region. In addition, fluorescently labeled CaM that has been introduced into the cardiomyocytes using the BioPORTER system moves from the cytoplasm to the nucleus with the development of HT. The immuno-confocal imaging of Ca(2+)/CaM-dependent protein kinase II (CaMKII) also shows cytoplasm-to-nucleus shift of the immuno-staining pattern in the hypertrophied cells. In an early phase of hypertrophic growth, the frequency of spontaneous Ca(2+) transients increases, which accompanies with cytoplasm-to-nucleus translocation of CaM. In a later phase of hypertrophic growth, further increase in the frequency of spontaneous Ca(2+) transients results in the appearance of trains of Ca(2+) spikes, which accompanies with nuclear translocation of CaMKII. The cardio-protective reagent dantrolene (the reagent that corrects the de-stabilized inter-domain interaction within the RyR2 to a normal mode) ameliorates aberrant intracellular Ca(2+) events and prevents nuclear translocation of both CaM and CaMKII, then prevents the development of HT. These results suggest that translocation of CaM and CaMKII from the cytoplasm to the nucleus serves as messengers to transmit the pathogenic signal elicited in the surface membrane and in the RyR2 to the nuclear transcriptional sites to activate HT program. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20433809      PMCID: PMC2878933          DOI: 10.1016/j.bbrc.2010.04.129

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

Review 1.  CaMKII, an emerging molecular driver for calcium homeostasis, arrhythmias, and cardiac dysfunction.

Authors:  Chad E Grueter; Roger J Colbran; Mark E Anderson
Journal:  J Mol Med (Berl)       Date:  2006-11-21       Impact factor: 4.599

2.  Defective regulation of interdomain interactions within the ryanodine receptor plays a key role in the pathogenesis of heart failure.

Authors:  Tetsuro Oda; Masafumi Yano; Takeshi Yamamoto; Takahiro Tokuhisa; Shinichi Okuda; Masahiro Doi; Tomoko Ohkusa; Yasuhiro Ikeda; Shigeki Kobayashi; Noriaki Ikemoto; Masunori Matsuzaki
Journal:  Circulation       Date:  2005-06-20       Impact factor: 29.690

3.  Differential regulation of cardiomyocyte survival and hypertrophy by MDM2, an E3 ubiquitin ligase.

Authors:  Ambrus Toth; Philip Nickson; Liu Liang Qin; Peter Erhardt
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

4.  Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca release channel.

Authors:  Naohiro Yamaguchi; Nobuyuki Takahashi; Le Xu; Oliver Smithies; Gerhard Meissner
Journal:  J Clin Invest       Date:  2007-04-12       Impact factor: 14.808

Review 5.  Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart.

Authors:  Lars S Maier; Donald M Bers
Journal:  Cardiovasc Res       Date:  2006-11-10       Impact factor: 10.787

6.  Defective domain-domain interactions within the ryanodine receptor as a critical cause of diastolic Ca2+ leak in failing hearts.

Authors:  Hiroki Tateishi; Masafumi Yano; Mamoru Mochizuki; Takeshi Suetomi; Makoto Ono; Xiaojuan Xu; Hitoshi Uchinoumi; Shinichi Okuda; Tetsuro Oda; Shigeki Kobayashi; Takeshi Yamamoto; Yasuhiro Ikeda; Tomoko Ohkusa; Noriaki Ikemoto; Masunori Matsuzaki
Journal:  Cardiovasc Res       Date:  2008-11-07       Impact factor: 10.787

7.  Defective regulation of the ryanodine receptor induces hypertrophy in cardiomyocytes.

Authors:  Tomoyo Hamada; Jaya P Gangopadhyay; Adel Mandl; Peter Erhardt; Noriaki Ikemoto
Journal:  Biochem Biophys Res Commun       Date:  2009-01-29       Impact factor: 3.575

8.  Ca2+/calmodulin-dependent protein kinase IIdelta and protein kinase D overexpression reinforce the histone deacetylase 5 redistribution in heart failure.

Authors:  Julie Bossuyt; Kathryn Helmstadter; Xu Wu; Hugh Clements-Jewery; Robert S Haworth; Metin Avkiran; Jody L Martin; Steven M Pogwizd; Donald M Bers
Journal:  Circ Res       Date:  2008-01-24       Impact factor: 17.367

9.  Identification of target domains of the cardiac ryanodine receptor to correct channel disorder in failing hearts.

Authors:  Takeshi Yamamoto; Masafumi Yano; XiaoJuan Xu; Hitoshi Uchinoumi; Hiroki Tateishi; Mamoru Mochizuki; Tetsuro Oda; Shigeki Kobayashi; Noriaki Ikemoto; Masunori Matsuzaki
Journal:  Circulation       Date:  2008-01-28       Impact factor: 29.690

Review 10.  Role of CaMKII for signaling and regulation in the heart.

Authors:  Lars S Maier
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  7 in total

1.  Aberrant interaction of calmodulin with the ryanodine receptor develops hypertrophy in the neonatal cardiomyocyte.

Authors:  Jaya P Gangopadhyay; Noriaki Ikemoto
Journal:  Biochem J       Date:  2011-09-01       Impact factor: 3.857

2.  Enhanced binding of calmodulin to the ryanodine receptor corrects contractile dysfunction in failing hearts.

Authors:  Akihiro Hino; Masafumi Yano; Takayoshi Kato; Masakazu Fukuda; Takeshi Suetomi; Makoto Ono; Wakako Murakami; Takehisa Susa; Shinichi Okuda; Masahiro Doi; Shigeki Kobayashi; Takeshi Yamamoto; Noritaka Koseki; Hiroyuki Kyushiki; Noriaki Ikemoto; Masunori Matsuzaki
Journal:  Cardiovasc Res       Date:  2012-08-14       Impact factor: 10.787

3.  Chronic hypoxia alters fetal cerebrovascular responses to endothelin-1.

Authors:  Jinjutha Silpanisong; Dahlim Kim; James M Williams; Olayemi O Adeoye; Richard B Thorpe; William J Pearce
Journal:  Am J Physiol Cell Physiol       Date:  2017-05-31       Impact factor: 4.249

4.  Nuclear translocation of calmodulin in pathological cardiac hypertrophy originates from ryanodine receptor bound calmodulin.

Authors:  Tetsuro Oda; Takeshi Yamamoto; Takayoshi Kato; Hitoshi Uchinoumi; Go Fukui; Yoriomi Hamada; Takuma Nanno; Hironori Ishiguchi; Yoshihide Nakamura; Yoko Okamoto; Michiaki Kono; Shinichi Okuda; Shigeki Kobayashi; Donald M Bers; Masafumi Yano
Journal:  J Mol Cell Cardiol       Date:  2018-10-22       Impact factor: 5.000

Review 5.  Visualizing CaMKII and CaM activity: a paradigm of compartmentalized signaling.

Authors:  Julie Bossuyt; Donald M Bers
Journal:  J Mol Med (Berl)       Date:  2013-06-18       Impact factor: 4.599

6.  Atrial Infarction-Induced Spontaneous Focal Discharges and Atrial Fibrillation in Sheep: Role of Dantrolene-Sensitive Aberrant Ryanodine Receptor Calcium Release.

Authors:  Uma Mahesh R Avula; Jonathan J Hernandez; Masatoshi Yamazaki; Carmen R Valdivia; Antony Chu; Alvaro Rojas-Pena; Kuljeet Kaur; Roberto Ramos-Mondragón; Justus M Anumonwo; Stanley Nattel; Héctor H Valdivia; Jérôme Kalifa
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-03

7.  Immunosuppressive activity of daphnetin, one of coumarin derivatives, is mediated through suppression of NF-κB and NFAT signaling pathways in mouse T cells.

Authors:  Bocui Song; Zhenning Wang; Yan Liu; Sisi Xu; Guoren Huang; Ying Xiong; Shuang Zhang; Linli Xu; Xuming Deng; Shuang Guan
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.